期刊文献+

FOXP3基因多态性与原发性肝细胞癌

FOXP3 gene polymorphisms and hepatocellular carcinoma
原文传递
导出
摘要 目的探讨转录因子FOXP3基因单核苷酸多态性(singlenucleotidepolymorphisms,SNPs)与原发性肝细胞癌(hepatocellularcarcinoma,HCC)的关系。方法采用飞行时间质谱法(MALDI-TOF)对392例肝癌患者和372例健康对照者FOXP3基因rs2280883和rs3761549位点单核苷酸多态性进行分析。结果肝癌组FOXP3基因SNP位点rs3761549C等位基因的频率明显高于健康对照组(OR=1.32,95%C/1.03~1.70,P=0.027)。肝癌患者FOXP3基因在rs2280883位点上出现TT基因型和在rs3761549位点上出现CC基因型的比例较健康对照者高,分别为79.6%和77.6%,并且携带rs2280883TT基因型或者rs3761549CC基因型的患者发生肝癌的风险也较高(OR=1.53,95%C/1.10~2.14;OR=1.92,95%C/1.39—2.64;P〈0.001)。分层分析肝癌患者的临床资料发现,rs3761549位点上CC基因型与原发性肝细胞癌发病的关联在发生门静脉癌栓的患者中更加显著(X^2=5.578,P=0.018),而且rs3761549位点上TT/CT基因型与原发性肝细胞癌发病的关联在出现肝癌复发的患者中更加显著(0=6.561,P=0.010)。结论FOXP3基因rs2280883和rs3761549位点的多态性与原发性肝细胞癌发病具有相关性,其中rs3761549位点CC基因型和TT/CT基因型分别与原发性肝细胞癌患者的门静脉癌栓发生和肝癌复发具有相关性。 Objective To investigate the correlation between single nucleotide polymorphisms (SNPs) of FOXP3 gene and the susceptibility of hepatocellular carcinoma (HCC). Methods Two SNPs rs2280883 and rs3761549 of FOXP3 gene in 392 HCC patients and 372 healthy controls were analyzed by Matrix-Assisted Laser Desorption/ Ionization Time of Flight Mass Spectrometry (MALDI-TOF). Results At rs3761549, C allele frequency was significantly higher ( OR = 1.32, 95% CI 1.03 - 1.70, P = 0. 027 ) in HCC patients than healthy controls. Compared with healthy controls, HCC patients had higher frequencies of TT genotype ( 79. 6% ) at rs2280883 or CC genotype ( 77.6% ) at rs3761549 of FOXP3 gene. Patients carrying rs2280883 TT genotype ( OR = 1.53, 95% CI 1.10 - 2. 14, P 〈 0. 00001 ) or rs3761549 CC genotype ( OR = 1.92, 95% CI 1.39 - 2. 64, P 〈 0. 00001 ) were more susceptible to HCC. Stratified analysis showed that rs3761549 CC genotype was significantly associated with higher incidence of portal vein tumor thrombus ( x^2 = 5. 578, P = 0. 018 ), and rs3761549 TT/CT genotype was significantly associated with higher rate of tumor recurrence in HCC patients (X^2 = 6. 561, P = 0.010 ). Conclusions FOXP3 gene polymorphisms at rs2280883 and rs3761549 might be associated with increased susceptibility to HCC. rs3761549, CC genotype and TT/CT genotype were respectively associated with higher incidence of portal vein tumor thrombus and tumor recurrence in HCC patients.
出处 《中华普通外科杂志》 CSCD 北大核心 2012年第2期127-130,共4页 Chinese Journal of General Surgery
基金 基金项目:国家自然科学基金资助项目(91029741,81001072) “十一五”科技重大专项基金资助项目(2008ZXl0002-008,2008ZXl0002-019)
关键词 肝细胞 多态性 单核苷酸 FOXP3基因 Carcinoma, hepatocellular Polymorphism, single nucleotide FOXP3 gene
  • 相关文献

参考文献10

  • 1樊嘉,王征.原发性肝癌基础研究及临床治疗的热点问题[J].中华普通外科杂志,2009,24(10):777-779. 被引量:7
  • 2Hiraoka N, Onozato K, Kosuge T, et al. Prevalence of FOXP3 + regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res, 2006, 12:5423-5434. 被引量:1
  • 3Bates GJ, Fox SB, Han C, et al. Quantification of regulatory T ceils enables the identification of high-risk breast cancer patients and those at risk of late relapse. J Clin Oncol, 2006, 24 : 5373- 5380. 被引量:1
  • 4Zheng Y, Rudensky AY. Foxp3 in control of the regulatory T cell lineage. Nat Immunol, 2007, 8:457-462. 被引量:1
  • 5Hinz S, Pagerols-Raluy L, Oberg HH, et al. Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer. Cancer Res, 2007, 67:8344-8350. 被引量:1
  • 6Ebert LM, Tan BS, Browning J, et al. The regulatory T cell- associated transcription factor FoxP3 is expressed by tumor cells. Cancer Res, 2008, 68:3001-3009. 被引量:1
  • 7Merlo A, Casalini P, Carcangiu ML, et al. FOXP3 expression and overall survival in breast cancer. J Clin Oncol, 2009, 27: 1746-1752. 被引量:1
  • 8FodorE, Garaczi E, Polyanka I-I, et al. The rs3761548 polymorphism of FOXP3 is a protective genetic factor against allergic rhinitis in the Hungarian female population. Hum Immunol, 2011, 72:926-929. 被引量:1
  • 9蓝艳,唐秀生,覃俊,武洁,覃集敏.转录因子FOXP3基因多态性与广西壮族系统性红斑狼疮的遗传易感性[J].中华医学遗传学杂志,2010,27(4):433-436. 被引量:8
  • 10Andre GM, Barbosa CP, Teles JS, et al. Analysis of FOXP3 polymorphisms in infertile women with and without endometriosis. Fertil Steril, 2011, 95:2223-2227. 被引量:1

二级参考文献18

  • 1Mahadevan D,Von Hoff DD.Tumor-stroma interactions in pancreatic ductal adenocarcinoma.Mol Caneer Ther,2007,6:1186-1197. 被引量:1
  • 2Gao Q,Qiu SJ,Fan J,et al.Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.J Clin Oncol,2007,25:2586-2593. 被引量:1
  • 3Cai MY,Xu YF,Qiu SJ,et al.Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection.Clin Cancer Res,2009,15:4686-4893. 被引量:1
  • 4Reya T,Morrison SJ,Clarke MP,et al.Stem cells,cancer,and cancer stem cells.Nature,2001,414:105-111. 被引量:1
  • 5Chiba T,Kita K,Zheng YW,et al.Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties.Hepatology,2006,44:240-251. 被引量:1
  • 6Yin S,Li J,Hu C,et al.CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity.Int J Cancer,2007,120:1444-1450. 被引量:1
  • 7Llovet JM,Ricci S,Mazzaferro V,et al.Sorafenib in advanced hepatocellular carcinoma.N Engl J Med,2008,359:378-390. 被引量:1
  • 8Kerbel RS.Antiangiogenic therapy;a universal chemosensitization strategy for cancer? Science,2006,312:1171-1175. 被引量:1
  • 9Jubh AM,Oates AJ,Holden S,et al.Predicting benefit from anti-angiogenic agents in malignancy.Nat Rev Cancer,2006,6:626-635. 被引量:1
  • 10Steeg PS.Angiogenesis inhibitors;motivators of metastasis?Nature Med,2003,9:822-823. 被引量:1

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部